Evidence map›Paper›PMID 34051859›Full record

ArticleSystematic reviews2021

Anti-epileptic drug exposure during pregnancy and neonatal birth weight outcomes: protocol for a systematic review and meta-analysis.

Alekhya Lavu, Christine Vaccaro, Walid Shouman, Silvia Alessi Severini, Sherif Eltonsy

Open access · goldAbstract read
In one paragraph

Article in Systematic reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alekhya LavuCollege of Pharmacy, University of Manitoba, 750 McDermot Ave W, Winnipeg, MB, R3E 0T5, Canada.
Christine VaccaroCollege of Pharmacy, University of Manitoba, 750 McDermot Ave W, Winnipeg, MB, R3E 0T5, Canada.
Walid ShoumanCollege of Pharmacy, University of Manitoba, 750 McDermot Ave W, Winnipeg, MB, R3E 0T5, Canada.
Silvia Alessi SeveriniCollege of Pharmacy, University of Manitoba, 750 McDermot Ave W, Winnipeg, MB, R3E 0T5, Canada.
Sherif EltonsyCollege of Pharmacy, University of Manitoba, 750 McDermot Ave W, Winnipeg, MB, R3E 0T5, Canada. sherif.eltonsy@umanitoba.ca.ORCID 0000-0002-0520-5406
University of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of epilepsy in pregnant women is estimated at 0.3-1%. Anti-epileptic drug (AED) exposure in-utero has been associated with various adverse health outcomes in neonates, including adverse birth weight outcomes.

objectiveThis review aims to summarize the published evidence on the association between AED exposure in pregnancy and adverse birth weight outcomes

methodsStudies assessing AED exposure in pregnancy and neonatal birth weight outcomes, including small for gestational age (SGA), low birth weight (LBW), birth weight (BW), length, head circumference, and cephalization index will be identified in MEDLINE®, EMBASE, Cochrane Library, Scopus, Cumulative Index of Nursing and Allied Health Literature (CINAHL), International Pharmaceutical Abstracts (IPA), and Global Health. Open grey, Theses Canada, and ProQuest Dissertations will be used to locate gray literature. Eligible study designs will include both intervention and non-interventional studies. We will not impose any time limit in the review. We will use the Newcastle-Ottawa Scale to assess the methodological quality of observational studies and quasi-experimental studies included in the review. The risk of bias of experimental studies will be appraised using the Cochrane risk-of-bias tool for randomized trials (RoB 2). A meta-analysis will be conducted using a random-effects model. DISCUSSION: The results from this review could improve clinicians' prescribing decisions by highlighting the safest AEDs for women who are pregnant or planning to conceive based on the evidence currently available. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42020192713.

Indexed as

Pharmaceutical PreparationsPregnancy ComplicationsBirth WeightCanadaFemaleHumansInfant, Low Birth WeightInfant, NewbornMeta-Analysis as TopicPregnancyPregnancy OutcomeReview Literature as TopicPharmaceutical PreparationsAnti-epileptic drugsBirth weight outcomesEpilepsyLow birth weightSmall for gestational age

Identifiers

PMID34051859
PMCPMC8164239
OpenAlexW3160875203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.